Literature DB >> 21730273

Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes.

Geoffrey R Oxnard1, Binsheng Zhao, Camelia S Sima, Michelle S Ginsberg, Leonard P James, Robert A Lefkowitz, Pingzhen Guo, Mark G Kris, Lawrence H Schwartz, Gregory J Riely.   

Abstract

PURPOSE: We use changes in tumor measurements to assess response and progression, both in routine care and as the primary objective of clinical trials. However, the variability of computed tomography (CT) -based tumor measurement has not been comprehensively evaluated. In this study, we assess the variability of lung tumor measurement using repeat CT scans performed within 15 minutes of each other and discuss the implications of this variability in a clinical context. PATIENTS AND METHODS: Patients with non-small-cell lung cancer and a target lung lesion ≥ 1 cm consented to undergo two CT scans within a period of minutes. Three experienced radiologists measured the diameter of the target lesion on the two scans in a side-by-side fashion, and differences were compared.
RESULTS: Fifty-seven percent of changes exceeded 1 mm in magnitude, and 33% of changes exceeded 2 mm. Median increase and decrease in tumor measurements were +4.3% and -4.2%, respectively, and ranged from 23% shrinkage to 31% growth. Measurement changes were within ± 10% for 84% of measurements, whereas 3% met criteria for progression according to Response Evaluation Criteria in Solid Tumors (RECIST; ≥ 20% increase). Smaller lesions had greater variability of percent measurement change (P = .005).
CONCLUSION: Apparent changes in tumor diameter exceeding 1 to 2 mm are common on immediate reimaging. Increases and decreases less than 10% can be a result of the inherent variability of reimaging. Caution should be exercised in interpreting the significance of small changes in lesion size in the care of individual patients and in the interpretation of clinical trial results.

Entities:  

Mesh:

Year:  2011        PMID: 21730273      PMCID: PMC3157977          DOI: 10.1200/JCO.2010.33.7071

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  20 in total

1.  Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility.

Authors:  Dag Wormanns; Gerhard Kohl; Ernst Klotz; Anke Marheine; Florian Beyer; Walter Heindel; Stefan Diederich
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

2.  Inherent variability of CT lung nodule measurements in vivo using semiautomated volumetric measurements.

Authors:  Lawrence R Goodman; Meltem Gulsun; Lacey Washington; Paul G Nagy; Kelly L Piacsek
Journal:  AJR Am J Roentgenol       Date:  2006-04       Impact factor: 3.959

3.  Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer.

Authors:  P Thiesse; L Ollivier; D Di Stefano-Louineau; S Négrier; J Savary; K Pignard; C Lasset; B Escudier
Journal:  J Clin Oncol       Date:  1997-12       Impact factor: 44.544

Review 4.  Making the investigational oncology pipeline more efficient and effective: are we headed in the right direction?

Authors:  Patricia M LoRusso; Aparna B Anderson; Scott A Boerner; Steven D Averbuch
Journal:  Clin Cancer Res       Date:  2010-12-15       Impact factor: 12.531

5.  Pulmonary metastases: effect of CT section thickness on measurement--initial experience.

Authors:  Binsheng Zhao; Lawrence H Schwartz; Chaya S Moskowitz; Liang Wang; Michelle S Ginsberg; Cathleen A Cooper; Li Jiang; John P Kalaigian
Journal:  Radiology       Date:  2005-01-28       Impact factor: 11.105

6.  Evaluation of tumor measurements in oncology: use of film-based and electronic techniques.

Authors:  L H Schwartz; M S Ginsberg; D DeCorato; L N Rothenberg; S Einstein; P Kijewski; D M Panicek
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

7.  Analysis of interobserver and intraobserver variability in CT tumor measurements.

Authors:  K D Hopper; C J Kasales; M A Van Slyke; T A Schwartz; T R TenHave; J A Jozefiak
Journal:  AJR Am J Roentgenol       Date:  1996-10       Impact factor: 3.959

8.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

9.  Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques.

Authors:  Samuel G Armato; Geoffrey R Oxnard; Heber MacMahon; Nicholas J Vogelzang; Hedy L Kindler; Masha Kocherginsky; Adam Starkey
Journal:  Med Phys       Date:  2004-05       Impact factor: 4.071

10.  Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.

Authors:  Jeremy J Erasmus; Gregory W Gladish; Lyle Broemeling; Bradley S Sabloff; Mylene T Truong; Roy S Herbst; Reginald F Munden
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544

View more
  59 in total

Review 1.  Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging concepts.

Authors:  Hee Kang; Ho Yun Lee; Kyung Soo Lee; Jae-Hun Kim
Journal:  Korean J Radiol       Date:  2012-06-18       Impact factor: 3.500

2.  Impact of radiation dose and iterative reconstruction on pulmonary nodule measurements at chest CT: a phantom study.

Authors:  Hyungjin Kim; Chang Min Park; Hee Dong Chae; Sang Min Lee; Jin Mo Goo
Journal:  Diagn Interv Radiol       Date:  2015 Nov-Dec       Impact factor: 2.630

Review 3.  The value of progression-free survival to patients with advanced-stage cancer.

Authors:  Lesley J Fallowfield; Anne Fleissig
Journal:  Nat Rev Clin Oncol       Date:  2011-10-18       Impact factor: 66.675

4.  Development and validation of a prediction model for measurement variability of lung nodule volumetry in patients with pulmonary metastases.

Authors:  Eui Jin Hwang; Jin Mo Goo; Jihye Kim; Sang Joon Park; Soyeon Ahn; Chang Min Park; Yeong-Gil Shin
Journal:  Eur Radiol       Date:  2017-01-03       Impact factor: 5.315

5.  Effect of censoring due to progressive disease on tumor size kinetic parameter estimates.

Authors:  Peter L Bonate; Ben Suttle
Journal:  AAPS J       Date:  2013-04-20       Impact factor: 4.009

Review 6.  Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?

Authors:  Sarah A Mattonen; Aaron D Ward; David A Palma
Journal:  Br J Radiol       Date:  2016-06-20       Impact factor: 3.039

Review 7.  [Oncological imaging for therapy response assessment].

Authors:  J Stattaus
Journal:  Radiologe       Date:  2014-01       Impact factor: 0.635

8.  Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy.

Authors:  Chikako Suzuki; Lennart Blomqvist; Thomas Hatschek; Lena Carlsson; Zakaria Einbeigi; Barbro Linderholm; Birgitta Lindh; Niklas Loman; Martin Malmberg; Samuel Rotstein; Martin Söderberg; Marie Sundqvist; Thomas M Walz; Gunnar Aström; Hirofumi Fujii; Hans Jacobsson; Bengt Glimelius
Journal:  Med Oncol       Date:  2013-01-16       Impact factor: 3.064

9.  Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals.

Authors:  Binsheng Zhao; Yongqiang Tan; Daniel J Bell; Sarah E Marley; Pingzhen Guo; Helen Mann; Marietta L J Scott; Lawrence H Schwartz; Dana C Ghiorghiu
Journal:  Eur J Radiol       Date:  2013-03-13       Impact factor: 3.528

10.  Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.

Authors:  Laurent Dercle; Lin Lu; Lawrence H Schwartz; Min Qian; Sabine Tejpar; Peter Eggleton; Binsheng Zhao; Hubert Piessevaux
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.